Stay updated on Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T23:49:40.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to include new drug identifiers and collaborators related to the study of pemetrexed and lenvatinib for treating nonsquamous non-small cell lung cancer, while significant details about the study's purpose and methodology have been removed.
    Difference
    23%
    Check dated 2025-04-17T11:09:47.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 21, 2025, while a date for March 25, 2025, has been removed.
    Difference
    0.2%
    Check dated 2025-04-10T05:59:53.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The web page has been updated to include new clinical trial details, including specific eligibility criteria for participants, treatment protocols, and updated timelines for results reporting. Notably, the study now specifies the inclusion of patients with a confirmed diagnosis of Stage IV nonsquamous NSCLC and outlines the treatment regimen involving multiple drugs over an extended period.
    Difference
    28%
    Check dated 2025-02-25T19:14:30.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.5%
    Check dated 2025-02-11T10:12:30.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.0%
    Check dated 2025-02-04T05:51:40.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Chemo +/- Lenvatinib in Lung Cancer Clinical Trial page.